Croda International (CRDA) AI Stock Analysis

• Market Cap: £4.11B
• Dividend Yield: 3.2%
• Average Volume (3M): 650.08K
• Price to Earnings (P/E): 29.5
• Beta (1Y): 1.33
• Revenue Growth: 2.36%
• EPS Growth: -13.99%
• Country: UK
• Employees: 6,027
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.72
• Shares Outstanding: 139,635,440
• 10 Day Avg. Volume: 610,745
• 30 Day Avg. Volume: 650,080
• PEG Ratio: -4.55
• Price to Book (P/B): 2.07
• Price to Sales (P/S): 2.90
• P/FCF Ratio: 34.35
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £3,204.00
• Price Target Upside: 8.24% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 10

• Rating: 70 Outperform
• Price Target: 3,188.00p ▲(7.70% Upside)

Croda International's overall stock score reflects strong earnings call performance and positive technical indicators. Financial performance is stable but challenged by declining margins. Valuation is a concern due to a high P/E ratio, though the dividend yield offers some compensation.

Croda International Business Overview & Revenue Model

Company Description

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. It operates through four segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. It also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and materials and polymer additives for electronics and devices. In addition, the company offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, it provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, the company offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

How the Company Makes Money

Croda International generates revenue primarily through the sale of its specialized chemical products across diverse sectors. The company has a clear revenue model based on the development and supply of high-performance ingredients that cater to specific client needs, allowing it to command premium pricing. Key revenue streams include the Personal Care sector, which focuses on skincare and haircare products; the Health Care segment that supplies excipients for pharmaceuticals; and the Crop Care division, which provides innovative solutions for agriculture. Croda also benefits from long-term partnerships with major global brands in various industries, enhancing customer loyalty and recurring sales. Additionally, the company's commitment to sustainability and innovation allows it to tap into emerging markets and trends, further contributing to its earnings.

Croda International Financial Statement Overview

Summary

Croda International shows solid financial health with a strong equity base and effective cost management. However, challenges include declining revenue and profitability margins. Stable cash flow generation suggests resilience, but potential pressures on growth and profit margins exist.

Income Statement

Croda International's income statement shows a contraction in total revenue from 2022 to 2024, with a negative trend in revenue growth rate. The gross profit margin remains strong at approximately 45%, indicating efficient cost management. However, the net profit margin has decreased, reflecting declining profitability. The EBIT and EBITDA margins are also decreasing, signaling weakening operating performance.

Balance Sheet

The balance sheet is relatively stable with a moderate debt-to-equity ratio. The company's equity ratio is robust, indicating a solid equity base. Despite a slight increase in debt over the years, there’s a consistent stockholders' equity, suggesting financial stability. However, the return on equity has been declining, which may affect investor confidence.

Cash Flow

The cash flow statements indicate stable operating cash flow, though free cash flow has shown minor fluctuations. The free cash flow to net income ratio is healthy, suggesting efficient cash conversion. Despite a decrease in free cash flow in the latest year, the operating cash flow to net income ratio remains strong, highlighting stable cash generation capacity.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.67B	1.63B	1.69B	2.09B	1.89B	1.39B
Gross Profit	614.80M	733.90M	730.00M	864.90M	825.60M	550.30M
EBITDA	355.50M	374.50M	388.50M	924.80M	549.40M	369.60M
Net Income	139.90M	158.50M	171.00M	649.30M	320.80M	201.60M
Balance Sheet
Total Assets	3.46B	3.51B	3.58B	3.61B	3.29B	3.03B
Cash, Cash Equivalents and Short-Term Investments	157.80M	166.80M	172.50M	320.60M	112.80M	106.50M
Total Debt	737.90M	699.10M	710.10M	615.80M	936.00M	907.00M
Total Liabilities	1.23B	1.21B	1.21B	1.18B	1.53B	1.43B
Stockholders Equity	2.22B	2.28B	2.35B	2.42B	1.75B	1.59B
Cash Flow
Free Cash Flow	79.80M	137.60M	156.80M	160.90M	190.50M	166.30M
Operating Cash Flow	226.60M	319.40M	337.50M	313.30M	349.20M	287.50M
Investing Cash Flow	-135.80M	-139.10M	-409.80M	418.10M	-218.40M	-992.40M
Financing Cash Flow	-128.20M	-182.60M	-52.40M	-550.90M	-111.90M	722.40M

Croda International Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2960.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRDA, the sentiment is Positive. The current price of 2960 is above the 20-day moving average (MA) of 2803.15, above the 50-day MA of 2642.51, and above the 200-day MA of 2852.67, indicating a bullish trend. The MACD of 70.25 indicates Negative momentum. The RSI at 67.70 is Neutral, neither overbought nor oversold. The STOCH value of 93.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CRDA.

Croda International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JMAT	76 Outperform	£3.52B	10.12	15.96%	3.59%	-9.10%	239.75%
TET	74 Outperform	£143.85M	13.41	8.02%	3.40%	1.12%	-0.70%
CRDA	70 Outperform	£4.11B	29.54	6.17%	3.20%	2.36%	-13.99%
VCT	70 Outperform	£576.65M	19.50	6.65%	8.94%	4.75%	-3.29%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ELM	60 Neutral	£964.13M	-17.17	3.37%	1.31%	-11.78%	-92.61%
SYNT	40 Neutral	£93.06M	-1.11	-7.26%	―	-4.41%	2.29%

Croda International Corporate Events

Croda International Achieves 6.5% Sales Growth in Q3 2025 Amid Challenging Market

Croda International reported a 6.5% increase in third-quarter sales for 2025, reaching £425 million, driven by growth in Beauty Actives, Fragrances and Flavours, and Crop Protection. Despite a challenging market environment, the company is on track with its transformation plan, aiming for £25 million in cost savings this year and £100 million by 2027, which supports its unchanged full-year outlook.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2870.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Announces Managerial Share Transactions

Croda International Plc announced a notification regarding transactions by individuals in managerial roles, involving the purchase of shares under the company’s Share Incentive Plan. This move reflects an internal alignment of interests between the company’s management and its shareholders, potentially strengthening stakeholder confidence and reinforcing the company’s market position.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £30.50 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Executives Reinforce Stakeholder Alignment with Share Purchases

Croda International Plc has announced a notification regarding transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. The transactions involved the purchase of ordinary shares under the company’s Share Incentive Plan through dividend reinvestment. This move reflects the ongoing commitment of the company’s executives and key personnel to align their interests with those of shareholders, potentially strengthening stakeholder confidence in Croda’s strategic direction.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £30.50 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Announces CFO Share Award Vesting

Croda International Plc has announced the vesting of a Buy-Out Award for its Chief Financial Officer, Stephen Richard Oxley, involving 2,051 ordinary shares. This transaction, conducted on September 30, 2025, underlines the company’s ongoing commitment to rewarding its key personnel through share-based incentives, potentially impacting stakeholder confidence and the company’s market positioning.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £31.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Announces Sharesave Scheme Options for Key Executives

Croda International Plc has announced the grant of options under its Sharesave Scheme for 2023, involving several key executives and committee members. This move is part of the company’s ongoing efforts to incentivize its leadership and align their interests with shareholders, potentially impacting the company’s operational focus and stakeholder engagement positively.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2688.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Aligns Management Interests with Shareholders Through Share Incentive Plan

Croda International Plc announced the purchase of shares under its Share Incentive Plan by Equiniti Share Plan Trustees Limited on behalf of persons discharging managerial responsibilities (PDMRs). This transaction, involving ordinary shares, is part of the company’s efforts to align the interests of its management with those of its shareholders, potentially impacting the company’s governance and stakeholder relations positively.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2688.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Reports Insider Share Purchase

Croda International Plc has disclosed a transaction involving the purchase of 545 ordinary shares by Andrew Caminow, a person closely associated with a person discharging managerial responsibilities. The transaction, valued at £13,898.81, took place on August 22, 2025, on the XLON market, reflecting ongoing insider activities within the company.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2688.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Director Acquires Shares, Signaling Confidence

Croda International Plc announced a transaction involving Mrs. Jacqueline Patricia Christine Ferguson, a Non-Executive Director, who purchased 393 ordinary shares at a price of £25.242740 each, totaling £9,920.40. This transaction, conducted on August 22, 2025, reflects ongoing confidence in the company’s market position and may influence stakeholder perceptions positively.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2775.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Announces Executive Share Transaction

Croda International Plc has announced a transaction involving Thomas Herman Riermeier, a member of its Executive Committee, who has been granted a Buy-Out Award under the company’s Buy-Out Share Plan 2025. This transaction, involving 2,852 ordinary shares, was conducted outside a trading venue and reflects Croda’s ongoing efforts to align managerial interests with company performance, potentially impacting stakeholder perceptions and executive incentives.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Announces Share Purchases by Key Management

Croda International Plc announced a series of transactions involving the purchase of shares under the company’s Share Incentive Plan. These transactions were conducted by the SIP Trustee on behalf of several key managerial personnel, including executive directors and committee members. The announcement highlights the company’s commitment to aligning the interests of its management with those of its shareholders, potentially impacting stakeholder confidence and market perception.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Director Purchases Shares, Signaling Confidence

Croda International Plc announced a transaction involving Christopher Good, a Non-Executive Director, who purchased 1,000 ordinary shares at a price of £26.32652 each. This transaction, conducted on August 6, 2025, on the XLON exchange, reflects the company’s ongoing commitment to transparency in managerial transactions and may indicate confidence in the company’s future performance.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International CEO Acquires Significant Shareholding

Croda International’s Chief Executive, Stephen Edward Foots, has made a significant purchase of the company’s ordinary shares, acquiring 3,815 shares at a price of £26.168118 each, totaling £99,831.37. This transaction, conducted on the London Stock Exchange, reflects a potential vote of confidence in the company’s future prospects and may impact investor perceptions and market positioning.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Executive Purchases Shares, Signaling Confidence

Croda International Plc has announced a transaction involving Michelle Angela Lydon, a member of its Executive Committee, who purchased 1,535 ordinary shares at a price of £25.91397 each, totaling £39,777.94. This transaction reflects insider confidence and may influence stakeholder perceptions of the company’s market position and future performance.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International’s Director Purchases Company Shares

Croda International Plc announced a transaction involving Ian Alan Bull, a Non-Executive Director, who purchased 500 ordinary shares at a price of £26.4295 each, totaling £13,214.75. This transaction, conducted on August 1, 2025, on the XLON exchange, highlights the ongoing engagement of the company’s leadership with its financial instruments, potentially reflecting confidence in the company’s market position and future prospects.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International CFO Exercises Share Award

Croda International Plc announced a transaction involving its Chief Financial Officer, Stephen Richard Oxley, who exercised an award under the company’s Buy-Out Share Plan 2025. This transaction, involving 2,763 ordinary shares, reflects the company’s ongoing commitment to aligning managerial interests with shareholder value, potentially impacting stakeholder confidence and market perception.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3800.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Director Purchases Shares, Signaling Confidence

Croda International Plc announced a transaction involving Danuta Gray, a Non-Executive Director, who purchased 1,300 ordinary shares at a price of £26.00227 each, totaling £33,802.95. This transaction indicates confidence in the company’s future prospects and may positively impact stakeholder perceptions, reinforcing Croda’s market position in the specialty chemicals sector.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3100.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Executive Buys Shares, Signaling Confidence

Croda International Plc announced a transaction involving Michelle Angela Lydon, a member of its Executive Committee, who purchased 355 ordinary shares at a price of £27.9885 each, totaling £9,935.92. This transaction reflects ongoing insider confidence in the company’s market position and potential growth, potentially impacting stakeholder perceptions positively.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £3100.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Reports Strong Growth Amid Challenges

The recent earnings call for Croda International painted a largely positive picture, with strong sales and profit growth across various segments. The company highlighted substantial cost-saving initiatives that bolstered its financial performance. However, challenges such as political uncertainties in the US and exceptional charges were noted as factors impacting profitability.

Croda CFO Purchases Shares, Signaling Confidence

Croda International Plc announced a transaction involving its Chief Financial Officer, Stephen Richard Oxley, who purchased 3,762 ordinary shares at a price of £26.71 each, totaling £100,483.02. This transaction, disclosed as an initial notification, reflects the company’s ongoing commitment to transparency and may indicate confidence in the company’s future performance, potentially impacting investor sentiment positively.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda Executive Purchases Shares, Signaling Confidence

Croda International Plc announced a transaction involving Thomas Herman Riermeier, a member of its Executive Committee, who purchased 1,000 ordinary shares at a price of £26.959 each. This transaction, conducted on July 29, 2025, at the London Stock Exchange, reflects insider confidence in the company’s prospects and could influence stakeholder perceptions positively.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Reports Strong First Half Sales Growth Amid Strategic Efficiency Drive

Croda International Plc reported a 7% increase in group sales at constant currency for the first half of 2025, driven by higher sales volumes across all its business sectors. Despite a challenging economic environment, the company maintained its full-year outlook and identified additional cost savings, aiming for £100 million in annualized savings by 2027. The strategic focus on operational efficiency and innovation is expected to strengthen Croda’s market position and improve returns, with adjusted operating profit up by 12% at constant currency.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Croda International Reports Strong H1 2025 Sales Growth Amid Strategic Efficiency Drive

Croda International reported a 7% sales growth at constant currency for the first half of 2025, driven by increased volumes across all business sectors, particularly in Beauty Care and Crop Protection. Despite a challenging environment, the company is on track with its strategic plan to enhance earnings and returns, with a focus on cost savings and operational efficiency, aiming for £100m in annualized savings by 2027.

The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.